Clinical Trials Logo

Clinical Trial Summary

The investigators propose to develop a smartphone app (called BetterOFF) that will help patients manage opioid withdrawal during opioid medication taper and detoxification. The BetterOFF smartphone intervention will be a resource patients can access anytime and anywhere. If the BetterOFF intervention were to be effective in helping patients discontinue opioid medication, it could be integrated into the standard of care of office-based clinical practices, as well as substance use programs, thereby having a substantial public health impact.


Clinical Trial Description

Many of the growing number of patients prescribed long-term opioid medication (for a variety of reasons including a history of illicit opioid use or management of chronic pain) will express an interest in discontinuing medication. However, many patients, physically dependent on opioids, fear the withdrawal symptoms that inevitably occur with opioid medication discontinuation and will experience a decrease in their self-efficacy for abstinence at the end of a taper. As a result, tapering is often slow and done hesitantly, and relapse rates after an opioid taper are high and associated with broad consequences, including significant negative physical, mental, and social problems. Even with optimal tapering protocols, patients need novel approaches to manage the discontinuation of opiate agonist treatment. Given this important gap in opioid treatment delivery, we propose to develop a theoretically-driven, smartphone-delivered intervention (Better Off app) to help patients effectively manage the experience of opioid medication discontinuation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03077932
Study type Interventional
Source Butler Hospital
Contact
Status Completed
Phase N/A
Start date April 1, 2016
Completion date June 30, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT03975192 - Neurostimulation for Opiate Withdrawal in the PICU N/A
Completed NCT03521960 - Buspirone for Opioid Tapering Phase 1
Enrolling by invitation NCT03012373 - Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts N/A
Completed NCT01945736 - Pharmacokinetics of Multiple Dose Methadone in Children Treated for Opiate Withdrawal
Not yet recruiting NCT03397212 - Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients Phase 4
Recruiting NCT05995535 - Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal Phase 2
Completed NCT05569031 - Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse Phase 4
Completed NCT03971097 - The Effect of Self-Forgiveness on Self-Stigma in Addiction. N/A
Recruiting NCT05029401 - A Study of Oral Ibogaine in Opioid Withdrawal Phase 1/Phase 2